Open AccessBuscopan or Glucagon for Endoscopic Cannulation of Ampulla of Vater?
Author(s) -
B.F. Hannigan,
S Avery,
A T Axon,
R. P. H. Thompson
Publication year - 1982
Publication title -
journal of the royal society of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.38
H-Index - 81
eISSN - 1758-1095
pISSN - 0141-0768
DOI - 10.1177/014107688207500106
Subject(s) - medicine , ampulla of vater , endoscopic retrograde cholangiopancreatography , duodenum , hyperamylasemia , glucagon , ampulla , significant difference , sphincter of oddi , anesthesia , surgery , pancreatitis , amylase , chemistry , carcinoma , biochemistry , enzyme , hormone
The number of intravenous injections of hyoscine-N-butylbromide (Buscopan) or glucagon required to maintain relaxation of the duodenum during endoscopic retrograde cholangiopancreatography (ERCP) were compared in a double blind trial of 55 patients. There was no significant difference in the number of injections. Serum amylase levels after the use of both relaxants were compared in 50 patients undergoing ERCP. No significant difference in the levels of hyperamylasaemia were found.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom